106 related articles for article (PubMed ID: 665833)
1. Evaluation of a slow-release lithium carbonate formulation.
Cooper TB; Simpson GM; Lee JH; Bergner PE
Am J Psychiatry; 1978 Aug; 135(8):917-22. PubMed ID: 665833
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of two lithium carbonate formulations.
Foster TS; Crass RE; Bustrack JA; Smith RB; Munson JW
Am J Hosp Pharm; 1980 Nov; 37(11):1528-31. PubMed ID: 7211858
[TBL] [Abstract][Full Text] [Related]
3. Absorption and disposition kinetics of lithium carbonate following administration of conventional and controlled release formulations.
Arancibia A; Corvalan F; Mella F; Concha L
Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):240-5. PubMed ID: 3089949
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of the controlled-release nisoldipine coat-core tablet formulation.
Heinig R; Ahr G; Hayauchi Y; Kuhlmann J
Int J Clin Pharmacol Ther; 1997 Aug; 35(8):341-51. PubMed ID: 9266290
[TBL] [Abstract][Full Text] [Related]
5. Absorption of lithium following administration of slow-release and conventional preparations.
Tyrer S; Hullin RP; Birch NJ; Goodwin JC
Psychol Med; 1976 Feb; 6(1):51-8. PubMed ID: 935297
[TBL] [Abstract][Full Text] [Related]
6. Steady-state lithium blood level fluctuations in man following administration of a lithium carbonate conventional and controlled-release dosage form.
Caldwell HC; Westlake WJ; Schriver RC; Bumbier EE
J Clin Pharmacol; 1981; 21(2):106-9. PubMed ID: 6785324
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability of lithium carbonate and lithium citrate: a comparison of two controlled-release preparations.
Tyrer SP; Peat MA; Minty PS; Luchini A; Glud V; Amdisen A
Pharmatherapeutica; 1982; 3(4):243-6. PubMed ID: 6815664
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability of a slow-release preparation of valproic acid under steady-state conditions.
Klotz U
Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):24-6. PubMed ID: 6799412
[TBL] [Abstract][Full Text] [Related]
9. A novel slow-release formulation of lithium carbonate (Carbolithium Once-A-Day) vs. standard Carbolithium: a comparative pharmacokinetic study.
Castrogiovanni P
Clin Ter; 2002; 153(2):107-15. PubMed ID: 12078335
[TBL] [Abstract][Full Text] [Related]
10. Comparison of plasma lithium levels and their interindividual variations with coated lithium carbonate tablets and a medium-slow-release lithium sulphate preparation (Lithionit Duretter).
Persson G
Acta Psychiatr Scand; 1977 Feb; 55(2):147-52. PubMed ID: 320831
[TBL] [Abstract][Full Text] [Related]
11. Single-dose bioavailability of two extended-release lithium carbonate products.
Kirkwood CK; Wilson SK; Hayes PE; Barr WH; Sarkar MA; Ettigi PG
Am J Hosp Pharm; 1994 Feb; 51(4):486-9. PubMed ID: 8017413
[TBL] [Abstract][Full Text] [Related]
12. Bioequivalence of a new sustained-release formulation of sodium valproate, valproate modified-release granules, compared with existing sustained-release formulations after once- or twice-daily administration.
Dulac O; Alvarez JC
Pharmacotherapy; 2005 Jan; 25(1):35-41. PubMed ID: 15767218
[TBL] [Abstract][Full Text] [Related]
13. Aspect of the pharmacokinetics of slow-release lithium carbonate.
Hart GA
S Afr Med J; 1984 Aug; 66(5):178-9. PubMed ID: 6431618
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of lithium preparations in patients.
Johnson GF; Hunt GE
Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):63-70. PubMed ID: 6427848
[TBL] [Abstract][Full Text] [Related]
15. Single dose pharmacokinetics of 5 formulations of lithium: a controlled comparison in healthy subjects.
Shelley RK; Silverstone T
Int Clin Psychopharmacol; 1986 Oct; 1(4):324-31. PubMed ID: 3104448
[TBL] [Abstract][Full Text] [Related]
16. [New sustained release form of lithium sulfate].
Ventouras K; Kick P; Buri P
Schweiz Med Wochenschr; 1973 Jun; 103(24):878-81. PubMed ID: 4712019
[No Abstract] [Full Text] [Related]
17. Comparison of side effects with coated lithium carbonate tablets and lithium sulphate preparations giving medium-slow and slow-release.
Edström A; Persson G
Acta Psychiatr Scand; 1977 Feb; 55(2):153-8. PubMed ID: 320832
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of standard and slow-release oral lithium carbonate products.
Wallis J; Miller R; McFadyen ML; Carlile JB
S Afr Med J; 1989 Dec; 76(11):618-20. PubMed ID: 2512655
[TBL] [Abstract][Full Text] [Related]
19. A pharmacokinetic analysis of lithium carbonate absorption from several formulations in man.
Caldwell HC; Westlake WJ; Connor SM; Flanagan T
J Clin Pharmacol New Drugs; 1971; 11(5):349-56. PubMed ID: 5208514
[No Abstract] [Full Text] [Related]
20. [The bioequivalence of two nifedipine sustained-release formulations after single administration in steady state].
Meyer FP; Banditt P
Arzneimittelforschung; 1993 Jun; 43(6):646-50. PubMed ID: 8352817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
